Global Closed System Transfer Devices Market Size, Share, and COVID-19 Impact Analysis, By Type (Membrane-To-Membrane Systems and Needleless Systems), By Component (Bag Spikes, Male Luers, Female Components, Vial Access Devices, and Others), By Closing Mechanism (Click-To-Lock Systems, Color-To-Color Alignment Systems, Luer-Lock Systems, and Push-To-Turn Systems), By End User (Hospitals & Clinics, Oncology Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Automotive & Transportation

RELEASE DATE Jul 2024
REPORT ID SI4957
PAGES 260
REPORT FORMAT PathSoft

Global Closed System Transfer Devices Market Insights Forecasts to 2033

  • The Global Closed System Transfer Devices Market Size was Valued at USD 1.3 Billion in 2023
  • The Market Size is Growing at a CAGR of 9.93% from 2023 to 2033
  • The Worldwide Closed System Transfer Devices Market Size is Expected to Reach USD 3.35 Billion by 2033
  • Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Global Closed System Transfer Devices Market

Get more details on this report -

Request Free Sample PDF

The Global Closed System Transfer Devices Market Size is Anticipated to Exceed USD 3.35 Billion by 2033, Growing at a CAGR of 9.93% from 2023 to 2033.

 

Market Overview

Closed System Transfer Devices (CSTDs) are specialized medical devices made to properly handle and dispense dangerous medications, especially those used in chemotherapy and oncology. By providing a closed channel for the delivery of pharmaceuticals, these devices reduce the possibility of contamination and shield medical personnel from hazardous materials. A closed system transfer device, sometimes called a closed system drug transfer device, is a device that is used to transfer medication in a way that prevents pollutants or toxins from the atmosphere from entering a system. This closed system transfer equipment is thought to preserve the quality of the solution that can be infused into a patient by preventing the uncontrolled input and outflow of contaminants and medications. Medication can be transferred from one reservoir to another using closed system transfer devices, or CSTDs, which reduce the possibility of drug aerosols, drug contamination, sharps exposure, and hazardous drug exposure. It physically stops harmful medication or vapor concentrations from escaping the system and from entering the system with contaminants from the environment. A closed system drug-transfer device (CSTD), according to the National Institute for Occupational Safety and Health (NIOSH), is a drug transfer device that helps and simultaneously mechanically inhibits the transfer of environmental pollutants into the system. It usually uses one of two design strategies a physical barrier or an air-cleaning device to stop hazardous medications from seeping into the environment. To maintain a sterile fluid channel, CSTDs are frequently utilized in medical equipment. They function by limiting the unregulated inflow and outflow of impurities and medications, protecting the purity of the solution that will be injected into a patient. Healthcare personnel handling hazardous pharmaceuticals should be completely safe while using CSTDs, but inappropriate handling or poor product design might be still lead to contamination being found.

 

Report Coverage

This research report categorizes the market for the global closed system transfer devices market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global closed system transfer devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global closed system transfer devices market.

 

Global Closed System Transfer Devices Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 1.3 Billion
No. of Pages:260
Tables, Charts & Figures:110
Segments covered:By Component, By Closing Mechanism, By End User, By Region
Companies covered:: Becton, Dickinson and Company, B. Braun Melsungen, Baxter International, Corning Incorporated, Vygon SA, Victus, West Pharmaceuticals Services, Yukon Medical, Corvida Medical, Cardinal Health, CODAN Medizinische Geräte GmbH & Co KG, Caragen, Equashield, ICU Medical, JMS, Practivet, Simplivia Healthcare, Terumo Corporation, and Others
Pitfalls & Challenges:Covid 19 Impact Challanges, Future, Growth and Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The increasing incidence of cancer is the primary factor propelling the growth of the closed system transfer devices market worldwide. As chemotherapy is one of the most popular treatments for cancer, there is a greater need for CSTDs to transfer or administer antineoplastic chemicals, which might be dangerous for medical personnel. Surface contamination during chemotherapy treatment can affect patients and their families as well as medical staff. As such, the increasing incidence of different cancers has increased the need for chemotherapy treatment, which has in turn increased the number of CSTDs prescribed by medical professionals to prevent the potentially harmful side effects of antineoplastic drugs. This has propelled the market's expansion. The market for closed system transfer devices is expanding due to the growing need to check compliance for safe pharmaceutical handling. Antineoplastic medications have the potential to improve or preserve a patient's life, but they can also be harmful to healthcare providers' health. This might occur if there is surface contamination or if medications escape during preparation, administration, or patient delivery. The cancer center's pharmacy staff prepares all dosages of chemotherapy medications under the guidance of a licensed pharmacist.

 

Restraining Factors

A major barrier to the widespread usage of closed system transfer devices is their high cost. Lack of funding and healthcare personnel's ignorance of the dangers of handling hazardous drugs are two main barriers to CSTD adoption that might impede the expansion of the closed-system transfer device industry. To guarantee appropriate usage and adherence to legal requirements, healthcare personnel must get training before integrating closed system transfer devices into workflows. Healthcare institutions might have difficulties in adopting CSTDs due to their complexity and the requirement for comprehensive training programs, which might result in opposition or delays.

 

Market Segmentation

The global closed system transfer devices market share is classified into type, component, closing mechanism, and end user.

 

  • The membrane-to-membrane systems is expected to hold the largest share of the global closed system transfer devices market during the forecast period.   

Based on the type, the global closed-system transfer devices market is divided into membrane-to-membrane systems and needleless systems. Among these, membrane-to-membrane systems is expected to hold the largest share of the global closed-system transfer devices market during the forecast period. Membrane-to-membrane systems use a double-membrane structure to form a strong barrier that stops pollutants and dangerous medications from escaping. By lowering the possibility of exposure to hazardous materials, this design provides excellent safety for patients and healthcare professionals during the preparation and delivery of drugs. Healthcare workers might quickly and efficiently transfer pharmaceuticals between vials or containers with membrane-to-membrane systems, which usually don't need complicated construction or manipulation. This user-friendliness lowers the possibility of user mistake during drug-handling operations and improves workflow efficiency.

 

  • The vial access devices segment is expected to hold the largest share of the global closed system transfer devices market during the forecast period.   

Based on the components, the global closed system transfer devices market is divided into bag spikes, male luers, female components, vial access devices, and others. Among these, the vial access devices segment is expected to hold the largest share of the global closed system transfer devices market during the forecast period. Standard medicine delivery tools including syringes, IV bags, and infusion pumps that are often used in healthcare settings are compatible with arterial access devices. Without the need for extra equipment or adjustments, healthcare professionals might effortlessly include vial access devices into their current medication delivery processes and systems because to their interoperability. Vial access devices make it easier to move drugs from vials to syringes or other administration devices in an effective and regulated manner. Vial access device design reduces the possibility of drug leakage, contamination, or spillage during medication extraction and transfer processes, guaranteeing precise dosage and cutting down on drug waste.

 

  • The luer-lock systems segment is expected to hold the largest share of the global closed system transfer devices market during the forecast period.   

Based on the closing mechanism, the global closed system transfer devices market is divided into click-to-lock systems, color-to-color alignment systems, luer-lock systems and push-to-turn systems. Among these, the luer-lock systems segment is expected to hold the largest share of the global closed system transfer devices market during the forecast period. Luer-lock systems are made to work with a wide range of medical equipment, such as infusion sets, IV catheters, and syringes. Due to this compatibility, healthcare practitioners can apply luer-lock CSTDs with their current processes and equipment without difficulty, reducing the requirement for new purchases or adjustments. In addition, luer-lock systems are simple to use and comprehend, which makes it simple for medical practitioners to include them into their everyday practices. Syringes and other devices can be securely attached and detached thanks to the luer-lock mechanism, which makes medication preparation and delivery processes more effective.

 

  • The hospitals & clinics segment is expected to hold the largest share of the global closed system transfer devices market during the forecast period.   

Based on the end users, the global closed system transfer devices market is divided into hospitals & clinics, oncology centers, and others. Among these, the hospitals & clinics segment is expected to hold the largest share of the global closed system transfer devices market during the forecast period. Chemotherapy and other strong medicines are among the numerous dangerous medications handled at hospitals and clinics. The demand for CSTDs in various healthcare settings is driven by the need to guarantee safe handling procedures and reduce the danger of exposure to hazardous chemicals. Furthermore, hospitals and clinics place a high focus on patient safety. By reducing the possibility of contamination, unfavorable responses, and medication errors during the preparation and administration of drugs, closed system transfer devices improve patient outcomes and safety.

 

Regional Segment Analysis of the Global Closed System Transfer Devices Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the global closed system transfer devices market over the predicted timeframe.

 

 Global Closed System Transfer Devices Market

Get more details on this report -

Request Free Sample PDF

North America is anticipated to hold the largest share of the global closed system transfer devices market over the predicted timeframe. Strict regulations govern the handling of hazardous medications in North America, especially the United States. One such regulation is the obligation to use CSTDs in healthcare settings. Moreover, the high rate of cancer in North America makes the regular use of chemotherapy medications necessary. The need for CSTDs in the region is further fueled by the necessity to reduce the dangers involved with handling hazardous medications in oncology settings. North America is dedicated to a highly developed healthcare system that includes reputable cancer centers, hospitals, and clinics. These hospitals possess the infrastructure and financial capacity to make investments in cutting-edge medical technology, such as CSTDs, to improve patient outcomes and safety. The extensive use of CSTDs in the region is facilitated by this large investment in healthcare technology and infrastructure.

 

Asia Pacific is expected to grow at the fastest pace in the global closed system transfer devices market during the forecast period. The presence of major companies in the Asian nations might be credited with the industry's growth in the region over the anticipated years. Apart from this, the region's sector might increase due to improvements in healthcare facilities and a rise in the amount of money major product manufacturers invest in R&D programs to introduce novel products with advantageous characteristics.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global closed system transfer devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Becton, Dickinson and Company
  • B. Braun Melsungen
  • Baxter International
  • Corning Incorporated
  • Vygon SA
  • Victus
  • West Pharmaceuticals Services
  • Yukon Medical
  • Corvida Medical
  • Cardinal Health
  • CODAN Medizinische Geräte GmbH & Co KG
  • Caragen
  • Equashield
  • ICU Medical
  • JMS
  • Practivet
  • Simplivia Healthcare
  • Terumo Corporation
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Developments

  • In October 2023, The FDA gave the EQUASHIELD LLC. (US) Syringe Unit further approval for full-volume usage. The requirements for medicine compounding and administration are effectively solved by this approval.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global closed system transfer devices market based on the below-mentioned segments: 

 

Global Closed System Transfer Devices Market, By Type

  • Membrane-To-Membrane Systems
  • Needleless Systems

 

Global Closed System Transfer Devices Market, By Component

  • Bag Spikes
  • Male Luers
  • Female Components
  • Vial Access Devices
  • Others

 

Global Closed System Transfer Devices Market, By Closing Mechanism

  • Click-To-Lock Systems
  • Color-To-Color Alignment Systems
  • Luer Lock Systems
  • Push-To-Turn Systems

 

Global Closed System Transfer Devices Market, By End User

  • Hospitals & Clinics
  • Oncology Centers
  • Others

 

Global Closed System Transfer Devices Market, Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1. Which are the key companies that are currently operating within the market?
    Becton, Dickinson and Company, B. Braun Melsungen, Baxter International, Corning Incorporated, Vygon SA, Victus, West Pharmaceuticals Services, Yukon Medical, Corvida Medical, Cardinal Health, CODAN Medizinische Geräte GmbH & Co KG, Caragen, Equashield, ICU Medical, JMS, Practivet, Simplivia Healthcare, Terumo Corporation, Others.
  • 2. What is the size of the global closed system transfer devices market?
    The global closed system transfer devices market is expected to grow from USD 1.3 Billion in 2023 to USD 3.35 Billion by 2033, at a CAGR of 9.93% during the forecast period 2023-2033.
  • 3. Which region is holding the largest share of the market?
    North America is anticipated to hold the largest share of the global closed system transfer devices market over the predicted timeframe.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies